Source author record

Zoe Guan

Zoe Guan appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Topical Hidden Genome: Discovering Latent Cancer Mutational Topics using a Bayesian Multilevel Context-learning Approach

Statistical inference on the cancer-site specificities of collective ultra-rare whole genome somatic mutations is an open problem. Traditional statistical methods cannot handle whole-genome mutation data due to their ultra-high-dimensionality and extreme data sparsity -- e.g., >30 million unique variants are observed in the ~1700 whole-genome tumor dataset considered herein, of which >99% variants are encountered only once. To harness information in these rare variants we have recently proposed the "hidden genome model", a formal multilevel multi-logistic model that mines information in ultra-rare somatic variants to characterize tumor types. The model condenses signals in rare variants through a hierarchical layer leveraging contexts of individual mutations. The model is currently implemented using consistent, scalable point estimation techniques that can handle 10s of millions of variants detected across thousands of tumors. Our recent publications have evidenced its impressive accuracy and attributability at scale. However, principled statistical inference from the model is infeasible due to the volume, correlation, and non-interpretability of the mutation contexts. In this paper we propose a novel framework that leverages topic models from the field of computational linguistics to induce an *interpretable dimension reduction* of the mutation contexts used in the model. The proposed model is implemented using an efficient MCMC algorithm that permits rigorous full Bayesian inference at a scale that is orders of magnitude beyond the capability of out-of-the-box high-dimensional multi-class regression methods and software. We employ our model on the Pan Cancer Analysis of Whole Genomes (PCAWG) dataset, and our results reveal interesting novel insights.

preprint2020arXiv

Combining Breast Cancer Risk Prediction Models

Accurate risk stratification is key to reducing cancer morbidity through targeted screening and preventative interventions. Numerous breast cancer risk prediction models have been developed, but they often give predictions with conflicting clinical implications. Integrating information from different models may improve the accuracy of risk predictions, which would be valuable for both clinicians and patients. BRCAPRO and BCRAT are two widely used models based on largely complementary sets of risk factors. BRCAPRO is a Bayesian model that uses detailed family history information to estimate the probability of carrying a BRCA1/2 mutation, as well as future risk of breast and ovarian cancer, based on mutation prevalence and penetrance (age-specific probability of developing cancer given genotype). BCRAT uses a relative hazard model based on first-degree family history and non-genetic risk factors. We consider two approaches for combining BRCAPRO and BCRAT: 1) modifying the penetrance functions in BRCAPRO using relative hazard estimates from BCRAT, and 2) training an ensemble model that takes as input BRCAPRO and BCRAT predictions. We show that the combination models achieve performance gains over BRCAPRO and BCRAT in simulations and data from the Cancer Genetics Network.